WO2000023803A1 - Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes - Google Patents

Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes Download PDF

Info

Publication number
WO2000023803A1
WO2000023803A1 PCT/US1999/023860 US9923860W WO0023803A1 WO 2000023803 A1 WO2000023803 A1 WO 2000023803A1 US 9923860 W US9923860 W US 9923860W WO 0023803 A1 WO0023803 A1 WO 0023803A1
Authority
WO
WIPO (PCT)
Prior art keywords
array
arrays
analyte
substrate
binding
Prior art date
Application number
PCT/US1999/023860
Other languages
English (en)
Inventor
Larry S. Millstein
Original Assignee
Millstein Larry S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/021860 external-priority patent/WO1999019711A1/fr
Application filed by Millstein Larry S filed Critical Millstein Larry S
Priority to CA002347125A priority Critical patent/CA2347125A1/fr
Priority to AU65158/99A priority patent/AU6515899A/en
Publication of WO2000023803A1 publication Critical patent/WO2000023803A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00351—Means for dispensing and evacuation of reagents
    • B01J2219/00427—Means for dispensing and evacuation of reagents using masks
    • B01J2219/0043—Means for dispensing and evacuation of reagents using masks for direct application of reagents, e.g. through openings in a shutter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00351—Means for dispensing and evacuation of reagents
    • B01J2219/00427—Means for dispensing and evacuation of reagents using masks
    • B01J2219/00432—Photolithographic masks
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00457—Dispensing or evacuation of the solid phase support
    • B01J2219/00475—Sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00513—Essentially linear supports
    • B01J2219/00518—Essentially linear supports in the shape of tapes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00527—Sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00585—Parallel processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/0059—Sequential processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00596—Solid-phase processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614—Delimitation of the attachment areas
    • B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623—Immobilisation or binding
    • B01J2219/00626—Covalent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00659—Two-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00675—In-situ synthesis on the substrate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00702—Processes involving means for analysing and characterising the products
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00709—Type of synthesis
    • B01J2219/00711—Light-directed synthesis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00725—Peptides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00727—Glycopeptides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00731—Saccharides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00734—Lipids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/12—Libraries containing saccharides or polysaccharides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Definitions

  • Arrays are important in many technologies, and methods to make arrays precisely, efficiently and economically are of widespread importance. Recently, the value of arrays with small dimensions has been recognized and interest is high in finding methods to produce a wide variety of small scale arrays commercially.
  • the divide and conquer strategy requires separate analysis channels for each test. Complexity thus increases directly in proportion to the number of tests performed.
  • the divide and conquer approach disadvantageously limits the test-effective sample amount and incurs additive sample manipulation, fabrication and apparatus costs that become increasingly onerous as the number of tests and the number of samples increases.
  • oligonucleotide probes for sequencing-by-hybridization onto a flat surface using a contact spotter of this type See Drmanac et al., Nature Biotechnology 16_: 54-58 (1998) which is herein incorporated by reference in its entirety.
  • oligonucleotide probes for a hybridization assay were dispensed by a micro-ink jet spotter directly onto the surface of a CCD. (See Eggers et al., BioTechniques Z: 516-524 (1994) which is herein incorporated by reference in its entirety).
  • oligonucleotide probes have been spotted onto flow-through chips using both contact spotting and ink jet methods, as described by Beattie and colleagues and developed by Gene Logic. (See, for instance, Beattie et al., WO 95/11755 which is herein incorporated by reference in its entirety.)
  • the spotting approach requires machinery capable of flawlessly depositing precise volumes of material at precise locations on a substrate, repeatedly.
  • To make 10,000 array replicates of a 10,000 member array using spotting methods requires 100,000,000 spots and, therefore, at least 100,000,000 spotting operations. Accuracy and precision are very difficult to maintain over such a large number of operations, needless to say, and this can limit the use of spotting approaches, particularly for large scale production of complex arrays.
  • spot size probably cannot be reduced below about 100 microns in diameter in practical spotting devices. If so, spotted arrays will be limited to densities of less than 10,000 assays per square centimeter and will not be suitable for many applications.
  • a second approach that has been used to make assay arrays involves solid phase synthesis on a surface controlled by photo lithographic techniques.
  • Affymax and Affymetrix have used light-addressable peptide and oligonucleotide solid phase synthesis chemistries to build up checkerboard-like arrays of short peptides or oligonucleotides.
  • Affymax scientists initially reported synthesis of an array of 1 ,024 peptides and since then they have reported much larger arrays. (See, for instance, Fodor et al. , Science 251: 767-773 (1991 ), Pirrung et al. , WO 90/15070 and Pirrung et.
  • Affymetrix scientists have reported a variety of oligonucleotide arrays. (For early results see Pease et al., PNAS 01 5022-5026 (1994) which is incorporated by reference herein in its entirety.)
  • One set of four arrays produced by Affymetrix included 20 pairs of 25- mer oligonucleotide probes for all 6,200 genes predicted by analysis of a complete yeast genomic sequence. (See Wodicka et al., Nature Biotechnology
  • Arrays like these are used intensively in drug discovery programs to identify disease and therapy associated changes in gene expression and to identify promising targets for drug discovery and development.
  • Affymetrix scientists also have reported oligonucleotide arrays useful for SNP discovery and screening. These include arrays for discovering human SNPs and arrays for sequencing human mitochondrial DNA.
  • the array for mitochondrial sequencing contained 135,000 oligonucleotide probes able to interrogate and in most cases determine the complete sequence of human mitochondrial DNA in a sample, in a single experiment. Arrays of this type are particularly useful for SNP mapping and for pharmacogenomics studies. Both types of arrays demonstrate the power and potential of arrays for all-at-once determinations on a large scale.
  • assay diversity in this approach depends on combinatorial build-up chemistries. Because of this it is limited to combinatorial polymers, such as nucleic acids and peptides, and, it generally requires knowing the sequences prior to the synthesis. Thus, the approach is not useful for complex molecules that cannot be synthesized and it is not effective without sequence information to guide synthesis. It does not lend itself to mixed arrays containing different kinds of immobilized reagents. The approach relies on reiteration of fairly complex steps and typically provides a low yield of array members in a high background of side products. Array members are formed in situ and cannot be processed, purified or assayed before use.
  • the approach depends on high precision and reproducibility of complex synthesis steps, as well as uniformity of yield across a large number of differing products.
  • Photo lithographic implementations require complex, high precision machinery and extremely high levels of skill, equipment and investment as does semiconductor manufacturing, from which it is partly derived. Photo lithographic approaches, thus, are as expensive as integrated circuit manufacturing, prohibitively so for many applications.
  • the array approach also is being applied to the discovery of new and useful inorganic materials, an approach spearheaded by Symyx, Inc. For instance, Symyx scientists combined thin film deposition and physical masking techniques adapted from the semiconductor fabrication industry to synthesize arrays (spatially addressable libraries) of solid state materials to screen for properties of interest.
  • Arrays of inorganic compounds have been fabricated by this approach and screened for superconducting properties. These arrays contained up to 10,000 samples per square inch. Sample areas were squares as small as 200 micrometers on each side. (See Xiang et al., Science 26 ⁇ : 1738-1740 (1995) which is herein incorporated by reference in its entirety.) Similar arrays made by this approach were screened for large magnetoresistance. (See Briceno et al., Science 2ZQ: 273-275 (1995) which is herein incorporated by reference in its entirety.) More recently, a rare-earth phosphor of useful properties was discovered by combinatorial synthesis and parallel screening techniques using this approach.
  • array members in temporally adjacent cycles are bound to and/or in and/or within segments that overlap or are adjacent to one another.
  • adjacent segments and/or the array members in and/or on and/or within the segments may be overlapping, non-overlapping but with edge to edge contact or non-overlapping and not in contact.
  • Non-overlapping segments are particularly preferred in certain preferred embodiments.
  • a plurality of array members is introduced into a corresponding plurality of channels in an array forming substrate or device, one or more introduced array members are bound to and/or in and/or within a segment of the corresponding channel and an array is formed by the array members bound to and/or in and/or within segments in the plurality of channels.
  • the corresponding segments of different channels lie along a line.
  • corresponding segments lie along a line orthogonally disposed to the parallel orientation of the channels.
  • the array members are bound to segments aligned orthogonally to parallel channels form a right angle array.
  • the array members form a checkerboard-like array.
  • the channels are non-communicating channels.
  • channels in particularly preferred embodiments are parallel to one another.
  • non- communicating channels are parallel to one another.
  • the channels are dimensionally similar or the same as one another.
  • channels differ from one another.
  • parallel non-communicating channels are grouped in banks (referred to herein generally as channel banks).
  • the banks comprise adjacent channels.
  • banks are dimensionally similar or the same as one another and comprise similar or the same number of channels.
  • the banks are comprised exclusively of adjacent channels.
  • preferred substrates for forming arrays are comprised of two members joined together. Particularly preferred embodiments in this regard related to channeled substrates in formed of two members.
  • one member comprises a surface for forming an array and the other member comprises a surface dimensioned and/or shaped to form channels when the two members are joined together.
  • the array forming surface is flat.
  • the two members when joined form a rigid or a flexible film or ribbon. In some aspects of the invention a flexible film or ribbon is preferred.
  • array members are attached and/or bonded, and/or joined, and/or bound and/ or immobilized to and/or on and/or within a substrate or device on and/or in and/or within which they form an array by activating a bonding and/or joining and/or binding and/or immobilization process in segments of the substrate or device so as to bind specific array members thereto.
  • a photochemical reaction is activated to bind array members.
  • a photo "cross-linking" reaction is activated.
  • a photolytic reaction is activated.
  • a combination of photo-linking and photolytic reactions are activated.
  • the light used for activation is visible light or UV light.
  • devices, exposures, reagents and techniques used for the photo-lithography and photo-lithographic processes for manufacturing integrated circuits are used to activate segments of substrates and devices for forming arrays and to bind array members.
  • the invention relates to arrays of binding reagents.
  • the binding reagents bind one or more cognate analytes.
  • the binding reagents are effective for detecting and/or quantifying cognate analytes.
  • Preferred binding reagents include purified molecules, mixtures thereof, complexes, aggregates and or other compositions of matter effective for binding a cognate. It is a further aspect of the invention in this regard certain preferred embodiments provide methods for making devices comprising surface having immobilized in discrete, predetermined, identifiable positions thereon a plurality of analyte-binding molecules.
  • the cognates are polynucleotides having sequences complementary to one another.
  • the polynucleotides in the array are oligonucleotides.
  • cognates are an antigen and an antibody or antibody-derived antigen-binding reagent and an antigen or antigen- analog.
  • binding cognates are a glycan or glycosylated molecule and a lectin that binds thereto, a receptor and a ligand, an aptamer and its target, or another biological or synthetic binding pair.
  • Additional aspects of the invention relate to using arrays.
  • the information relates to one or more of the following: individual device identifier, processing lot number or numbers, type of device, date of manufacture, expiration date, quality control information relating to functional aspects of the device or the array, information necessary to use the device or array and information supplied by the user.
  • the information on device identity is required to use the device.
  • relating particularly to devices comprising arrays for detecting and/or quantifying analytes information about each assay in the device may be provided.
  • the device is an autoanalyser which delivers reagents.
  • reagents for developing the assays are an integral part of the device.
  • FIGURES are provided to aid understanding of the invention herein disclosed. They portray certain specific illustrative embodiments and aspects of the invention. They do not portray the invention in its entirety in any respect and they do not portray limitations of the invention.
  • FIGURE 1 shows a process of the invention for forming an array.
  • the first cycle (C1 ) of the process starts at (S1 ) with several substrates (rectangles
  • the substrates may be separate pieces or different portions of the same piece, such as a set of channels in a ribbon substrate.
  • the substrates are exposed to the array members.
  • the substrates may be exposed to different array members or the same ones.
  • II step three (S3) sectors of the substrates are activated to bind array members.
  • step (S4) substrates are cleared of unbound material leaving array elements bound to the activated sectors of each substrate.
  • the cycle of exposure, activation, and clearing is repeated in a second (C2) and subsequent cycle (...Cq).
  • C2 second
  • ...Cq subsequent cycle
  • the process forms the n X q array illustrated at lower right.
  • the figure depicts but one relatively simple embodiment. For instance, the stippling does not represent the differences or complexity possible for array members exposed to the substrates. Steps other than the four depicted here may be employed (as figuratively indicated by the vertical ellipsis).
  • the geometry of the substrates and the array elements need not be uniform or governed by right angles. Not all substrates must be filled in each cycle, nor must they all be emptied, to mention just a few aspects of the many embodiments of the invention, which generally are further described elsewhere herein.
  • FIGURE 2A shows several general methods for producing many arrays at the same time. Substrates (vertical lines) are organized into several identical
  • CB1 CB2 . . . CBn e.g. banks of channels in a ribbon.
  • the substrates pass several Activating Stations (large boxes AS1 AS2 . . . ASp).
  • Each Activating Station contains a set of Activating Lines (thin horizontal boxes AL1 AL2 . . . ALq). that operate together.
  • a process according to Figure 1 is carried out in all the substrates at the same time using all the activating lines. All the
  • FIGURE 2B shows a section of the ribbon in greater detail.
  • CB, AL and ua are as for Figure 2A.
  • the arrow at A indicates the activation dimension.
  • the arrow at F indicates the flow dimension. Sixteen unit arrays are pictured.
  • FIGURE 3A provides a schematic illustration of an activating device.
  • Light from a source (1 ) is focused by a lens (2) onto a slit plate (3) to activate a region (4) on a binding surface of a flow channel and thereby bind a reagent disposed in the lumen (6) of the flow channel.
  • (5) is the lower member of the channel
  • (7) is the upper member
  • (6) is the lumen.
  • (8) somewhat fancifully depicts light scattering as it moves away from the focal point (4) through the lumen (6) and the upper member (7) of the flow channel and out of the ribbon.
  • FIGURE 3B depicts a moving activation device positioned at two different points along a fixed ribbon.
  • FIGURE 3C depicts a moving ribbon in two different positions under a fixed activation device.
  • FIGURE 4A illustrates from the side features of a device for manufacturing a large number of arrays using a parallelized process of the type depicted in Figures 1 and 2, and an activation instrument along the Lines presented in Figure 3.
  • a long ribbon (2) containing the flow channels passes above an activation station containing four activating Lines (1 ).
  • the ribbon is wound on spools (3 and 6) at each end of the device.
  • the spools can pass the ribbon back and forth so that it can be activated repeatedly anywhere along its length.
  • reagents generally need to be loaded only once into the flow channels to be immobilized at all the desired positions in the ribbon.
  • Reagents are introduced into and removed from the ribbon through manifolds (4 and 5) at each end.
  • the activation area is environmentally isolated by barriers (solid and dashed Lines (7)).
  • the device would include connected quality control instruments for determining, among other things, uniformity of solutions in the flow channels and the efficiency and uniformity of binding after activation (not shown).
  • FIGURE 4B illustrates from the bottom the ribbon and slit plate of the device shown from the side in Figure 4A. It depicts the channel ribbon (2) passing over the four activation Lines (1 ).
  • the slits that define the areas of activation are exaggerated. In some preferred embodiments, for instance, they would be around 10 to 100 micrometers wide while the ribbon would be on the order of 10 to 100 centimeters across. The ribbon would be 10,000 times wider then the slit that runs across it in these embodiments.
  • FIGURES 5A - 5E show a method for forming a ribbon with flow channels as follows.
  • FIGURE 5A shows a portion of a channel-forming film. Relative dimensions of ribs, channels thickness are not representatively proportional.
  • FIGURE 5B shows a film that provides a flat smooth binding surface.
  • FIGURE 5C show the two films bonded together to form square channels.
  • FIGURE 5D shows reagents (stippling) in the channels. While channels typically will be filled, they are portrayed partially filled to enhance perspective.
  • FIGURE 5E shows an array of reagents affixed to the binding surface, with the channel-forming film removed. Elevation of the reagents above the surface is exaggerated from typical arrays.
  • FIGURE 6 illustrates some features that can be incorporated in an assay area.
  • the analyte binding reagent or other material to be immobilized is illustrated by the 15 square elements in the center of the area, arranged in a 3 X 5 grid.
  • Each of the square elements can provide redundancy or uniquely different immobilization features, such as a graded series of concentrations of the array member, such as an analyte binding reagent.
  • Alignments markers triangles with cross hatch) set off the right and left sides of each row in the grid.
  • a "start" point, such as for reading results, is marked by the horizontally striped triangle to the left square element 1. Ends of the intermediate and last rows are marked by a down-pointing triangle with vertical stripes and a diagonally striped square, respectively.
  • the corners of the assay area are set off asymmetrically, a different marker shape in each corner.
  • Machine-readable coding areas are indicated by one rectangular area above the grid (horizontal striping) and three below the grid (vertical striping). The elements of the grid, the alignment and other markers and the coding areas can be formed using marks during activation, much the same as photo-lithographic processes.
  • FIGURE 7 illustrates assembly of chips into sub-assemblies and modules. The top of the figure shows a chip with 400 spots.
  • FIGURE 8A illustrates from the side a device for contacting a chip with samples and reagents for analysis.
  • (1 ) is a chip module.
  • (2) is a sample delivery port.
  • (3) is a reagent delivery port.
  • (4) is a reagent exit port.
  • (5) is a channel for sample and reagent, which runs from the sample and reagent entry ports directly over the chip module to the reagent exit port.
  • (6) is three areas for human and/or machine readable information on the device.
  • FIGURE 8B illustrates from the side the device shown in Figure 8A.
  • the chip module (1 ), sample loading septum (2), reagent delivery septum (3), reagent exit septum (4), and reagent channel can be seen particularly clearly in this view.
  • FIGURE 8C shows a side view of the device joined to reagent delivery manifold.
  • (7) indicates the direction of sample loading into the sample loading port, which is covered by a septum (dark rectangle (2)).
  • (8) is a reagent delivery manifold with reagent delivery port (9) and reagent removal port 10.
  • O-ring gaskets black circles provide a fluid-tight seal between the device and the manifold.
  • the present invention relates generally to methods of making arrays, to arrays, to using arrays, to devices for making arrays, and to devices for using arrays, among other things.
  • the invention relates to methods for making arrays by contacting array members with a substrate, activating part of the substrate to bind one or more of the array members with which it is in contact, binding the array member or members thereto, and preparing the substrate to repeat the cycle of contacting, activating and binding and clearing with additional array members, whereby binding array members to different parts of the substrate in succeeding cycles fabricates an array of the array members bound to the substrate.
  • the invention also relates to the arrays thereby formed, to devices for carrying out such methods to form arrays, to uses and ways of using the arrays, to information that can be obtained thereby and to uses of the information.
  • FIG. 1 shows a process for making arrays in accordance with certain preferred embodiments of the invention.
  • the figure illustrates a process beginning at the upper left with step one (S1 ) of cycle one (C1 ), which provides several empty blanks of a substrate, depicted as rectangles 1 , 2, 3 ... n).
  • step one S1
  • cycle one C1
  • the substrate blanks are contacted with array members shown as stippling in the rectangles.
  • step three of the illustrated process S3 an activating process or agent, represented by a horizontal open rectangle is applied to a portion (referred to below as a sector) of the substrate blanks.
  • array members bind activated portions of the substrate and they remain bound when the substrate blanks are cleared of unbound material in step four (S4).
  • Arrays members bound to activated sectors of the substrate at the end of one iteration of this process are illustrated as stippled areas in rectangles 1 , 2, 3 ... n, at bottom left in the figure.
  • the cycle of contacting (S2), activating and binding (S3) and clearing (S4) then is repeated a number of times (C2 ... Cq at top), activating different sectors in different cycles, to build up an array.
  • Array members bound to substrate at the end of a second cycle are shown at bottom middle (stippled areas in rectangles 1 , 2, 3 ... n at S4 under C2).
  • the array formed after a number of cycles, q, is shown at bottom right
  • an array is an arrangement of array members. Often it is convenient to define an arrangement by positions of array members relative to one another in an array. A given arrangement may be defined in this way by the relative positions of some but not necessarily all of the array members in an array.
  • array members are in fixed positions in an arrangement.
  • the invention is useful to produce replicate arrays all having the same arrangement of array members.
  • array members are disposed in the same arrangement relative to one another in all replicates of a given array.
  • the array members have the same fixed positions in all replicates of a given array.
  • some or all array elements in individual replicates vary in positions relative to one another. Where the arrangement varies between replicates, in preferred embodiments of the invention, the array members can be identified by other information.
  • array members may be anything to be arrayed or arrayed.
  • array members may be atoms, molecules, thin films, ceramics, glasses, metals, polymers, compounds, compositions, gels, mixtures, combinations of the foregoing and just about any other composition of matter. Preferred are those that have or are useful to identify or determine in other substances physical, electrical, magnetic, electromagnetic, chemical, biochemical, biological and other properties of interest.
  • Examples of preferred embodiments in this regard include those that: bind analytes, absorb light, fluorescence, quench fluorescence, phosphorescence, those that are chemiluminescent, electroluminescent, sonoluminescent, piezoelectric, those that are polymers, metals, alloys, ceramics, organic compounds, inorganic compounds, biomolecules and biomaterials of interest, such as those to be screened for desired properties or those to be used as screening agents for properties of other substances, and combinations of any of the foregoing.
  • polypeptides including partial or complete proteins and peptides
  • polynucleotides such as DNAs and RNAs, including relatively long polynucleotides and oligonucleotides, compounds that bind to polynucleotides sequence-specifically, such as peptide nucleotide acids and DNA sequence-specific polyamides, polysaccharides, ligands, ligand-binding biomolecules, molecules of pharmaceutical interest, chelating agents or those that bind to chelating agent-derivatives, fractions of cells or tissues, parts of cells or tissues, whole cells, whole living cells, derivatives and modified forms of the foregoing, and mixtures of any of the foregoing, to name just a few.
  • arrays of the invention are not limited to any particular type of array member, and the foregoing examples, as well as other examples set forth elsewhere herein are necessarily merely illustrative.
  • binding reagents such as, but not limited to, DNAs, RNAs and other polynucleotides, polynucleotide-derivatives, such as PNAs and other polymeric compounds, such as certain polyamides, that bind to polynucleotides in a sequence-specific manner, antibodies and antibody-derived binding reagents, antigens, ligands, receptor polypeptides and derivatives thereof, aptamers, that bind specifically to cognate compounds or to cognate groups of compounds, such as DNA or RNA aptamers and polypeptide aptamers, to name just a few examples in this regard.
  • binding reagents such as, but not limited to, DNAs, RNAs and other polynucleotides, polynucleotide-derivatives, such as PNAs and other polymeric compounds, such as certain polyamides, that bind to polynucleotides in a sequence-specific manner, antibodies and antibody-derived binding reagents, antigen
  • array members may be formed in any shape.
  • an array member may be round, oval, ellipsoidal, triangular, square, rectangular, trapezoidal, pentagonal, hexagonal, octagonal, other regular or irregular polygon or any other regular or irregular shape.
  • the array members are uniformly shaped.
  • the array members are homogeneous.
  • the array members are both homogeneous and uniformly shaped.
  • An array member may be formed within or on a substrate or device for forming an array.
  • an oligonucleotide array member may be synthesized, purified and characterized in advance and then bound to one or more segments of a substrate or device to form part of an array, by a process such as that depicted in Figure 1. The same process can be used as well to synthesize array members on an array support or substrate or device for forming one or more arrays.
  • the process depicted in Figure 1 can be used to (1 ) bind to preferably preselected segments an array of first bases for solid phase polynucleotide synthesis; (2) carry out successive deprotection and addition reactions and (3) carry out deblocking reactions of typical solid phase methods to synthesize oligonucleotides in situ in the array.
  • solid phase oligonucleotide synthesis can be carried out on a glass or silicon according to a process much like that depicted in Figure 1 using light-mediated, positionally defined, deprotection to build up oligonucleotides of defined sequences at defined positions in an array.
  • peptide array members also may be similarly synthesized.
  • array members can be attached to segments in a precursor form and altered into final form after attachment.
  • Array members can have a wide variety of sizes and spacing, including but not limited to the following.
  • Particularly preferred are 100-1 ,000, 1 ,000-5,000, 5,000-10,000, 10,000- 50,000, 50,000-100,000, 100,000-500,000, 500,000-1 ,000,000, 1 ,000,000- 10,000,000 and more than 10,000,000 array members in an array. Especially particularly preferred are less than 1 ,000, 1 ,000-10,000, 10,000-100,000, 100,000-1 ,000,000 and more than 1 ,000,000 array members in an array.
  • array members have cross-sectional areas of about 0.0025-0.0075, 0.005-0.015, 0.01-0.03, 0.025-0.075, 0.05-0.15, 0.1-0.3, 0.25-0.75, 0.5-1.5, 1.0-3.0, 2.5-7.5, 5.0-15, 10-30, 25-75, 50-150, 100-300, 250- 750, 500-1 ,500, 1 ,000-3,000, 2,500-7,500, 5,000-15,000, 10,000-30,000, 25,000-75,000, 50,000-150,000, 100,000-300,000, 250,000-750,000, 500,000- 1 ,500,000, 1 ,000,000-3,000,000, 2,500,000-7,500,000, 5,000,000-15,000,000 and 10,000,000-30,000,000 ⁇ m 2 .
  • Array members can be spaced in arrays to suit a variety of applications. Preferably in many applications array members are spaced about 0.05-0.15, 0.1- 0.3, 0.25-0.75, 0.5-1.5, 1.0 -3.0, 2.5-7.5, 5.0-15, 10-30, 25-75, 50-150, 100-300, 250-750, 500-1 ,500, 1 ,000-3,000, 2,500-7,500 or 5,000-15,000 micrometers apart.
  • the density of array members in arrays preferably is about 10-100, 50- 250, 100-350, 200-400, 150-750, 500-1 ,000, 750-2,500, 2,000-4,000, 2,500- 7,500, 5,000-10,000, 7,500-15,000, 10,000-50,000, 25,000-75,000, 50,000- 150,000, 100,000-300,000, 250,000-750,000, 500,000-1 ,500,000, 1 ,000,000-
  • the flat cross sectional surface area of arrays are much different than the total surface area.
  • preferred density of array members in the arrays is about 10-100, 50-250, 200-800, 500-1 ,000, 750-2,500, 2,000-4,000, 2,500-7,500, 5,000-10,000, 7,500-15,000, 10,000-50,000, 25,000- 75,000, 50,000-150,000, 100,000-300,000, 250,000-750,000, 500,000- 1 ,500,000, 1 ,000,000-3,000,000, 2,500,000-7,500,000 or 5,000,000-15,000,000 array members per square centimeter of total surface area.
  • Array members also can be of a variety of depths.
  • array members are 0.1-0.3, 0.25-0.75, 0.5-1.5, 1.0 -3.0, 2.5-7.5, 5.0-15, 10-30, 25-75, 50-150, 100- 300, 250-750, 500-1,500, 1 ,000-3,000 or 2,500-7,500 micrometers deep.
  • Substrates for forming arrays in accordance with the invention can be formed of a wide variety of materials, as discussed in the "Materials" section below.
  • substrates for forming arrays may have any shape.
  • Cross sections of channels in certain preferred embodiments described in detail elsewhere herein may be, for instance, round, oval, ellipsoidal, triangular, square, rectangular, trapezoidal, pentagonal, hexagonal, octagonal and other regular or irregular polygons or any other regular or irregular shape.
  • Such channels moreover, can have one lumen, a few lumen, such as 1 to 10 lumen, or many lumen, such as 11 to 100 or 101 to 200 or 201 to 500 or 500 to 1 ,000 or more than 1 ,000.
  • the particular shape employed, the number and size of lumen, the disposition of any coating and of array members with respect to a structural member can be adjusted to best suit a given application and array.
  • Substrates and parts thereof for binding array members can also can be of practically any size, which typically is dictated by the desired size of the array members in the array.
  • SUBSTRATE MATERIALS Virtually any material can be used for making arrays in accordance with the invention. The choice of materials for a given array will depend on details of the array members, how they will be mounted and used, and other details relating to specific embodiments in specific circumstances.
  • materials suitable for use in the invention include any materials that can be shaped into a desired form. Generally, materials that are relatively easy to form are preferred. Particularly preferred are materials that can be shaped to very high precision and very small feature sizes. Thus, particularly preferred materials possess the ability to form a desired configuration with specified dimensions and properties, including, but not limited to desired thickness and density (including having channels); the ability to bind array members; and tolerance for various treatments including for instance, those associated with making arrays and those associated with use of arrays. Among such particularly preferred materials are those that can be formed into long ribbons or films, such as those of embodiments described more specifically elsewhere herein. Also preferred are materials that can be wafered conveniently, with high precision and close tolerances, and in some aspects of the invention very small geometries.
  • materials that are compatible with array members are materials that are compatible with array members. That is, materials that do not deleteriously interact with or affect array members during the processes or uses of array formation, including but not limited to clearing, loading, activating and binding array members to sectors on substrates or devices, such as channels, particularly channels in ribbons or films as described elsewhere herein, to other conditions to which arrays may be subjected during manufacture processing, assembly, production, storage, shipment or use.
  • preferred materials are those that are compatible, in much the same regard, with downstream process steps and end uses. In one aspect in this regard, materials with a high degree of dimensional stability are preferred. In another aspect, materials resistant to solvents and materials used in downstream process steps and end uses are preferred. In another aspect in this regard, materials are preferred that facilitate detection, particularly for analyte detecting and/or determining applications of the invention.
  • plastics and/or polymers include, among a great many others, polycarbonate, polyethylene, methylmethacrylate, polypropylene, polyester, (poly)tetrafluoroethylene, (poly)vinylidenenedifluoride and the like.
  • plastics and polymers that can be used in the invention are well known to those skilled in the art, such as those described in, among other well known references, Modern Plastics, Encyclopedia '97, Volume 73, Nov. 1996 and The
  • certain preferred embodiments relate to processing substrates and/or wafers and/or arrays and/or array members before and, during or after array formation to alter, among others, one or more dimensions, one or more structures and/or one or more properties of a substrate and/or one or more array members and/or an array.
  • substrates, array members and/or arrays are processed to alter dimensions of wafers comprising arrays and/or arrays and/or array members.
  • substrates are made of one or more materials that can be formed readily, preferably under relatively mild conditions.
  • a film comprising channels of given, relatively small dimensions can be formed from an appropriately dimensioned stock of appropriate larger dimensions.
  • Wafers can be made in just about any given shape or geometry. Faces, sides and facets of the wafer also can be formed with just about any shape, geometry and/or texture. Wafers can be formed from substrates directly into a desired geometry or first formed in one shape and then modified. Sides, faces, facets, surfaces and other features of wafers may be uniform or not. They may be flat or they maybe contoured in any one or more of a wide variety of shapes. For instance, wafers may be made with one or more surfaces that are, for instance, rippled, grooved, trenched, roughened, polished and the like. In certain aspects of the invention in this regard preferred embodiments provide regularly shaped wafers comprising on one face one or more arrays, each array being disposed on a uniform flat surface.
  • wafers and wafer surfaces such as faces, sides and facets can be produced and/or modified by cutting, milling, drilling, forming, abrading, smoothing, pulling, extruding and other forming techniques well known to the fabrication arts, particularly techniques used to shape, form and finish metal, ceramic, glass and plastic. Such techniques are to employed in accordance with the invention generally so as not to adversely affect either the structure or the performance or arrays or of array members.
  • the units or groups of units may be cut apart from each other, using any one or more of a wide variety of suitable cutting techniques.
  • substrates may be designed to facilitate later separation of unit arrays or of groups of unit arrays.
  • substrates may be formed with perforations, for instance, between units or groups of units that will be separate.
  • grooves or troughs may be incorporated between units or groups in the substrate to facilitate separation.
  • the cutting method should be effective for all the materials in the array.
  • the cutting method should be compatible with the array and the substrate materials, particularly the array members and any other components important to further processing or to using the array being produced. Methods that minimize waste are particularly preferred. Thus, where mechanical cutting is employed, methods that minimize kerf are preferred in this regard. Methods that minimize contamination are preferred as well. Cutting methods that do not foul or close openings are preferred. Generally, preferred cutting methods also minimize environmental stresses, such as heat, that often results from cutting and forming processes. Likewise preferred are methods that avoid altogether or minimize exposing the units or substrate abrasives, lubricants, solvents, coolants or the like, especially those could deleteriously affect the array members, the arrays or functional aspects thereof.
  • microtome cuts do not produce discernable contamination across the cut surface and cut without distorting shape.
  • Microtome knife edges make uniform cuts both as to individual cuts and serially from cut to cut. Generally the cuts do not generate heat and they do not require lubricant, solvents or cleaning solutions.
  • Ultra high pressure liquid cutting is another useful technique for cutting to produce or process wafers in accordance with the invention.
  • Ultra-fast jet streams of liquid such as those used to cut steel and other metals, provide a clean, precise, temperature controlled cut that can be quite useful in some embodiments of the present invention. Methods of this type are particularly preferred for cutting glass, metal and ceramics, particularly when microtomes cannot be used.
  • Laser cutting also is a preferred cutting technique in certain embodiments of the invention.
  • Other mechanical cutting devices that may be useful in the invention include rotary and reciprocating cutting devices, including circular saws, band saws and wire saws, to name just a few. Tools of this type can be used in the invention, in keeping with the foregoing considerations.
  • the substrate comprises channels and array members are bound to a surface of the channels.
  • the discussion below relates to especially preferred embodiments in this regard, in which the substrate comprises a plurality of non-communicating channels. It relates to further particularly preferred embodiments in which array members are introduced into the channels, sectors of the channels are activated to bind array members therein disposed, the unbound material is removed from the channels and the cycle of introducing array members, activating and binding, and then clearing the channels is repeated to build up an array.
  • the process is of the type depicted in Figure 1.
  • the discussion relates to especially preferred embodiments in which arrays are formed on a surface, in particular on one surface of the channels.
  • substrate is a long, thin ribbon and many arrays are formed at the same time by reiterating the array formation process both across the substrate and along its length.
  • substrate comprises identical groups of channels across its breadth, and array members are introduced into each group of channels in the same way during each cycle.
  • the discussion relates to preferred embodiments in which array forming areas are defined all along the length of the substrate, and sector activation is carried out in each cycle in the same way in all of the array forming areas during each cycle.
  • the following discussion relates to preferred embodiments in which the same array is formed in the array forming areas across the breath and along the length of the substrate.
  • the following discussion is provided for illustrative purposes. It relates to but a few of many possible embodiments of the invention. The dimensions and geometries thus are merely exemplary. Many other dimensions can be used for flow channels, ribbons, activation Lines, spacing, embedded information, manifolds, matrixes, carriers and the like.
  • the choice of dimensions generally will be a function of engineering and design considerations, such as the materials to be employed, the accuracy and precision of tools to be used for manufacturing, the number and type of assays to be mounted and the number of elements they are to contain, the nature of the immobilization chemistry, the methods to be used for activation, the accuracy and precision of the activation method, the assay development techniques to be used, the amount of sample and of reagents required, the nature of the detection scheme, such as the nature of the detectable label, the spacial and quantitative precision and accuracy of the detecting system, and the reproducibility of the overall process in a given embodiment, to name just a few parameters that will effect the design of a given implementation of the invention.
  • the manifold, the ribbon and the exposure areas are used to form chips that contain 400 different array members (referred to in the following discussion as AMs) in the following manner.
  • AMs are introduced into the 40 ports in the manifold and distributed to the same position channel In each group of 40 flow channels in the ribbon.
  • the AMs are in solution or in a gel and are uniformly distributed along the length of each flow channel in the ribbon.
  • an activating agent typically light. Exposure to light activates one of the surfaces of the flow channel to form covalent linkages to the AMs in the flow channels.
  • Unbound AMs are recovered from the channels.
  • the channels then are thoroughly purged of non-covalently bound AM.
  • a second set of 40 AMs is then introduced into the channels and immobilized by photo activated cross-linking area in the channels. The process is repeated until AMs are immobilized in all the exposure areas, 10 times for the
  • This process builds a chip having many different AMs covalently linked to its surface by a process that involves repeating 10 times the relatively simple steps of introducing 40 AMs into the manifold, activating the surface in an exposure area, and washing the channels.
  • a complete set of exposure cycles in this example produces chips .2 by 8 millimeters, since there are 10 exposure areas of 200 micrometers (with spacing) each along the length of the chip and 40 flow channels of 200 micrometers each across the width of the chip (150 micrometers with a 50 micrometer barrier).
  • Each chip can be made with 400 different AMs in 400 different positions.
  • AMs are introduced into the flow channels via a manifold.
  • the illustrative manifold of this example has
  • each port connects through the manifold to all of the channels in corresponding positions in each group of 40 channels. That is, the first port connects to all the first channels in every group of forty channels. That way, the first port distributes the connected reagent into all the corresponding channel in all the groups across the ribbon. The same is true for the other ports in the manifold.
  • each set of 40 reagents gets distributed through the manifold in the same order into each group of 40 flow channels across the width of the ribbon. Accordingly, the order of AMs in the channels will be the same in every chip formed from the ribbon.
  • a simple manifold in this regard can be made by forming the ribbon with flow channels from a much larger dimensioned starting blank, leaving both ends of the blank larger than the ribbon so that it is relatively easy to "wire” the appropriate connections.
  • An augmented approach of this type provides a "macro"- dimensioned manifold that mates to a "macro"-dimensioned end of the starting blank.
  • the manifold may be designed to connect directly to the flow channels in the ribbon, on one "side,” and to containers for reagents, such as AMs, buffers and the like, on the other "side.”
  • the ribbon also is figuratively divided along its length into regions defined by an activation line.
  • Activation is accomplished by photochemical means in this illustrative example and the activation line is defined by an illuminating beam that extends across the width of the ribbon perpendicularly (orthogonally) to its length.
  • the beam width defines the size of the activation/exposure region along the length of the channels.
  • the activation beam defines 10 activation regions of about 150 micrometers each, separated by about 50 micrometers.
  • the 10 activation Lines and spacing between them defines a region of about 2.0 millimeters along the length of the flow channels.
  • a bank of 40 flow channels together with the 10 activation Lines defines a chip 2.0 millimeters by 8.0 millimeters containing 400 assay areas about 200 micrometers by about 200 micrometers (including spacing) arranged in a 10 by 40 grid, ff ribbon can be wider than set out above and generally it will be longer than a single chip length, to facilitate production of a large number of chips. Accordingly, activation Lines can be banked so that each activation step is effectuated in several areas along the length of the ribbon. With banks of flow channels and banks of activation Lines, each cycle of ten activations will produce a grid of chips in a section of the ribbon. Illustrative embodiments of this aspect of the invention are depicted in Figure 2A and Figure 2B. In certain preferred embodiments in this regard, each set of AMs, 40 in this case, is immobilized in the appropriate positions all along the length of the ribbon before it is removed. Thus, each AM needs to be introduced to the ribbon only once during the chip-making process.
  • a surface of the flow channels is photosensitive and when exposed to light of appropriate wavelength and intensity it forms covalent bonds with the AMs in the flow channels binding them.
  • the exposure to the activating light in this example therefore photo lithographically defines the pattern of AMs immobilized in the flow channels.
  • An example reaction scheme for forming and using a photo-activatable surface in this regard employs commercially available alkylamine-polystyrene plastic and commercially available cross-linking agents.
  • a wide variety of photo- cross-linking agents that can be used in this regard are well known.
  • immobilization chemistries and procedures that can be used in this invention can be carried out as described in, or analogously to, e.g., U.S. Pat.
  • crosslinking agents can be utilized, including, e.g., photoactivatable arylazide-containing hetero-bifunctional reagents with an amino-reactive NHS ester include N-hydroxysuccinimidyl-4-azidosalicylic acid,
  • SAPB N-5-azido-2-nitrobenzoyloxy-succinimide
  • ANB-NOS N-succinimidyl-6- (4'-azido-2'-nitrophenyl-amino)hexanoate
  • SANPAH N-succinimidyl-6-(4'- azido-2'-nitrophenylamino)-hexanoate
  • sulfo-SANPAH N-succinimidyl 2->(4- azidophenyl)dithio!acetic acid
  • NHS-APDA N-succinimidyl-(4-azidophenyl)1 ,3'- dithiopropionate
  • SADP N-succinimidyl-(4-azidophenyl)-1 ,3'-dithiopropionate
  • sulfo-SADP sulfo-SADP
  • SAND sulfosuccinimidyl-2-(m-azido-o-nitrobenzamido)ethyl-1 ,3'- dithiopropionate
  • SASD sulfosuccinimidyl-2-(p-azidosalicylamido)-ethyl-1 ,3'- dithiopropionate
  • SASD N-hydroxysuccinimidyl 4-azidobenzoylglycyltyrosine (NHS-ABGT), sulfosuccinimidyl-2-(7-azido-4-4-methylcoumarin-3- acetamide)ethyl-1 ,3'-dithiopropionate (SAED), and sulfosuccinimidyl-7-azido-4- methylcoumarin-3-acetate (sulfo-SAMCA).
  • the chip may be used alone or with other, independently manufactured chips.
  • the grid depicted in the illustrative drawing contains 6 sub-assemblies of 5 chips each, for a total of 30 chips and 12,000 assays.
  • modularity provides important advantages. For instance, since each chip in an assembly is made independently of the others one manufacturing run can be used to make up for failures in a previous run.
  • activation need not be uniform on the exposed surface of the flow channel. Exposure can be varied in intensity in different areas. These different areas are illustrated as "elements" of Figure 6. Each exposure area thus may be made of many elements coated with different concentrations of an AM, also figuratively illustrated in Figure 6. Chips also generally can contain borders between elements and/or assay areas and areas associated with elements, assay areas or generally with the chip as a whole, such as area for embedding markers and information. Some embodiments in this regard are illustrated in Figure 6. As described elsewhere herein, the data may be imprinted during manufacture of the ribbon or may added to the ribbon after manufacture. Moreover, information may be encoded by or with the immobilization of the AMs in the flow channels themselves. Information may be in the form of pseudo AMs that are immobilized along with AMs or independently. Such pseudo AMs can provide information for registration, alignment, detection, internal control, calibration and the like.
  • the ribbon can be quite long and, therefore, well-suited to mass manufacturing processes.
  • Figures 1 provides a general schematic of the array forming process of this example as discussed in more detail elsewhere herein.
  • Figure 2 depicts a method implementation for forming many arrays at the same time in a long ribbon substrate, also as discussed in greater detail elsewhere herein.
  • FIG. 3A shows a device for photo-activating a ribbon substrate of the type discussed in this example.
  • Figures 3B and 3C show two ways to reposition the activating lines along the length of the substrate. These are discussed in greater detail below.
  • Figure 4A depicts a ribbon spooled at both ends of a device for activation and for quality control. The ribbon can be run over the activation platform in either direction with equal facility.
  • the illustrative embodiment in the figure includes a means for moving the ribbon so that it can be exposed in numerous positions along its length from one end to the other.
  • the ribbon can be unspooled and respooled on the drums at each end of the device so that each reagent for immobilization need be introduced once, and so that several groups of reagents can be introduced successively into the ribbon, as described elsewhere herein.
  • the device contains several illumination stations that comprise a light source, mask holder, clamping means to hold the ribbon in place, optical assembly, exposure indicator and positioning means, among other things.
  • An illuminator of this type is shown in greater detail in Figure 3A.
  • the platform also contains quality control modules for determining efficiency and uniformity of covalent bonding of each AM to each exposure area.
  • the spools contain ribbon manifolds for adding solutions.
  • the system is parallelized for high throughput.
  • the illustrated station could be on that illuminates 20 corresponding exposure areas at the same time. It operates in the following manner, much as described above.
  • the ribbon and manifolds are mounted on the spools. 40 AMs are introduced into the 40 ports in the manifold, filing all 20 banks of 40 flow channels in the ribbon.
  • the entire length of the ribbon is wound through the platform and passed over the QC units to identify inhomogeniety or irregularities in the distribution of the AM anywhere in the ribbon.
  • the ribbon and illumination means are moved so that the 20 first areas in the first 20 sets of 10 exposure areas each are properly positioned for surface activation.
  • the ribbon and illumination means are moved so that the 20 first areas in the next 20 sets of 10 exposure areas each are properly positioned for surface activation. This process is repeated until the first set of 40 AMs is properly immobilized in all the appropriate positions along the length of the ribbon. Then the same process is repeated with nine successive sets of 40 reagents in each set. It may be useful to note that the number of times activation must be carried out for a given fill of 40 reagents depends both on the ribbon length and on the number of Lines in the bank of activating Lines. Giving each chip 2.0 millimeters along the length of the ribbon there would be 10,000 chip regions along a ribbon 20 meters long.
  • AM binding can be assessed by QC units for every exposure. Abnormalities can be corrected or recorded and saved for use in later stages of the manufacturing process.
  • the liquid in the flow channels can be moved back and forth. Such motion can be used to check for bubbles or inhomogeniety of the fill. It can be used to distinguish surface bound AM from AM in solution.
  • Tags can be included in the solutions for this purpose, such as tags that bind to activated surfaces.
  • Non-immobilizing taggant can be used to facilitate monitoring liquid flow in the channels.
  • Labeled AM can be spiked into the AM for immobilization, likewise to monitor and control liquid flow in the channels, the immobilization reaction and the immobilization of the AM.
  • the first 40 AMs When the first 40 AMs are bound to all the intended positions in the flow channels they are removed from the ribbon. These reagents could be recovered -- in fact in some applications, for instance, where the process does not affect the AM solution and the amount of AM removed by immobilization is relatively small and does alter the concentration, the AM solution can be recovered and reused without further processing.
  • the flow channels After the first set of AM reagents is removed, the flow channels are thoroughly washed. Then, a second set of 40 AMs is introduced into the flow channels and they are bound to activated surfaces in the same way as the first set of 40 AMs. The second set of AM reagents then is removed and the channels are washed again. The process is repeated ten times, until all 10 exposure areas in each set of ten exposure areas have been activated and coated with an AM.
  • a coating solution or gel may be introduced into the flow-channels to protect the AM surface from dessication or mechanical damage during the following stages of the manufacturing process.
  • the ribbon is removed from the spools and the manifold.
  • the guide is removed from the AM surface.
  • Protective surface coating may occur at this stage rather than or in addition to the early coating step. Protective coating may be done as the guide is removed from the AM surface or thereafter.
  • the ribbon is then diced to provide assay surfaces for detection devices.
  • the ribbon may be diced to provide unit assay surfaces, or it may be diced to produce larger assay surfaces that contain redundancies.
  • the ribbon is cut in unit assay surfaces that are 2 millimeters by 8 millimeters. Dices of this size are relatively easy to handle, manually or by automated devices.
  • the dice pieces generally will be mounted in a carrier, which may be designed to accommodate one or more dice pieces.
  • the dice pieces in a carrier may be the same or different types. Generally, several different assay surfaces will be mounted together in a carrier.
  • each carrier can serve to increase the number of assays in the final device, provides for redundancy and provides several opportunities to mount a successful manufacture of each intended assay, so that the failure of any one assay in a manufacturing run does not necessitate discarding the entire product from that run. This also facilitates redundancy so that each carrier can have all the assays it was intended to have even if the manufacture of an assay in a particular ribbon was faulty.
  • the embodiment illustrated in Figure 6 has 30 chips mounted together in a matrix of 6 5-chip sub-assemblies. This configuration provides 30 chip-level opportunities to succeed in manufacturing any given assay. Assuming a failure rate of 20% overall, the 30 chips in the illustrated embodiment can comprise over 9,500 different assays that meet quality control requirements.
  • Ribbons suitable for use in the processes described above and elsewhere herein can be made in a variety of ways.
  • the flow channels are formed by bonding two thin films together.
  • One film has open-ended channels and serves as a channel former.
  • the other thin film in this illustrative example is a flat surface.
  • the production of thin films of these types is a highly developed industrial process practiced on a vast scale by many industries. Such films are produced for photography for instance. And, the same coating techniques used to make photographic film can be used to coat one or other or both surfaces for use in accordance with the present invention.
  • a flow channel lumen 150 micrometers wide, 200 micrometers high and 20 meters long has a volume of about 0.6 milliliters. Filling such a flow channel with a 5 ⁇ g/ml solution of an AM would require 3 micrograms of an AM. 20 flow channels in 20 banks across a 20 meter ribbon would require 60 micrograms of the AM. 60 micrograms thus would be enough to produce 200,000 chips that take up 2.0 millimeters along the ribbon length (such as the 2 by 8 millimeter chip with 400 assays described above).
  • the foregoing estimate does not take into account the possibility of recovering the AM-containing solution, rather than using it only once and then discarding it.
  • the amount of AM that bonds to the flow channel surface will be a very small fraction of the AM in the solution.
  • a flow channel contain the solution throughout, only one of ten exposure areas in the channel is involved in binding the AM.
  • 90% of the AM-containing solution will lie above the inert areas of the surface. Accordingly, 90% of the AM in the flow channel will remain unaffected by the immobilization process, for this reason alone.
  • the foregoing estimate is about reusing the solution 11 times, so that most or all of the antibody in the solution ultimately is immobilized would greatly reduce the amount of an AM required to manufacture large numbers of chips.
  • a typical ELISA immobilization procedure binds about 10 nanograms of an antibody to the surface of a standard microtiter plate well from 100 ⁇ l of a 1 ⁇ g/ml antibody solution. The surface area contacted by 100 ⁇ l in the well is about 100 mm 2 . (See, for instance, Table 2 on page 39 in Kemeny et al. (1988) supra.) This amounts to 100 picograms per mm 2 .
  • each assay area will occupy a total of 400 mm 2 .
  • the 10,000 chips would require 40 nanograms of each AM. This a small fraction of the 60 micrograms introduced into the channels, as discussed above.
  • Detecting and quantitating substances of various sorts in a wide variety of samples are important components of many economically important activities. For instance determining analytes, such as molecular, macromolecular and cellular analytes is important in biological, chemical, veterinary, clinical, forensic, agricultural, food, environmental, consumer products, process stream, quality control, military-related and other types of samples. Arrays, array-based devices, and array-related methods and apparatuses can be used for analysis of analytes in all of these types of samples, among others.
  • Analyte determining arrays can be used in this regard for, to name just a few examples, clinical and veterinary diagnostic analyte analysis, forensic analysis, food quality monitoring, agricultural monitoring, environmental monitoring, monitoring of microbial agents, chemical and biological warfare agent monitoring, and process control monitoring.
  • clinical and veterinary diagnostic analyte analysis forensic analysis
  • food quality monitoring agricultural monitoring
  • environmental monitoring monitoring
  • monitoring of microbial agents e.g., microbial agents
  • chemical and biological warfare agent monitoring e control monitoring.
  • sample Samples suitable for analysis in the present invention include any sample that can be brought into contact with assays in a chip for effective detection or quantification of an analyte.
  • Preferred samples are homogeneous liquid samples. Included are biological fluids such as blood, serum, urine, saliva, spinal fluid, tears, lymph, bile, peritoneal, and wound fluids. Also included are homogenized biological samples such as homogenized mucous and homogenized bowel samples, as well as homogenized biopsy samples. Preferred samples include the aforementioned biological fluids, of which blood, serum, urine and salvia are particularly preferred.
  • an ABR an analyte binding reagent
  • an ABR is any entity that binds to and can be used to detect the presence or determine the amount of an analyte.
  • An ABR and the analyte(s) it binds are referred to as cognates.
  • the ABRs bind their cognate analytes very tightly and with great specificity.
  • ABRs bind their cognate analytes much less tightly and with much less specificity.
  • ABRs are particularly useful in arrays that implement nose-like sensing paradigms.
  • Analytes can be detected and quantified by binding to one or to more than one ABR. molecule, compound, etc.
  • any atom, molecule, complex of molecules, mixture of molecules or molecular complexes, molecular aggregates, macromolecular or other complexes, aggregates, combinations of the foregoing or any other assemblage of matter can be used in accordance with the present invention if it is useful to the determination of any other assemblage of matter (as illustrated by the foregoing illustrative listing) and it can be incorporated into the devices of the invention or used in the methods and apparatus of the invention herein described.
  • chip means the same as wafer, and as unit, unit surface and dice.
  • element Usually the smallest feature on a chip is referred to as an element. Most often it constitutes a defined area that contains a particular analyte binding reagent.
  • the signal from an element may be obtained by sampling and calculation.
  • a laser (or other sensing element) for reading an array can be smaller than the array elements, in which case the smallest signal-generating area is defined by the laser, not the array.
  • assay The part or parts of a chip relating to a given assay or test is referred to as an assay or assay areas.
  • An assay may comprise one or more elements, which may be grouped or distributed in an array.
  • an assay may comprise a graded concentration of an ABR to provide a quantitative curve of analyte binding.
  • An assay also may comprise negative and positive controls.
  • autoanalyser An instrument for automatically processing sample test matrixes, generally comprising (1 ) a mechanism to transport carriers through the instrument, (2) a microprocessor controlled liquid delivery system that delivers appropriate reagents to the test matrix according to its type, (3) a system for digitizing all the assay results within each element in the matrix, and (4) a computerized analysis system to determine the results of each assay, to report the results, and to bill for the requested tests.
  • BIOSENSORS AN INTRODUCTION, Wiley and Teubner, Chichester and Stuttgart (1996), HANDBOOK OF BIOSENSORS AND ELECTRONIC NOSES, MEDICINE, FOOD, AND THE ENVIRONMENT, Erika Kress-Rogers, ed., CRC Press, Boca Raton (1997) and IMMUNOCHEMICAL ASSAYS AND BIOSENSOR TECHNOLOGY FOR THE 1990S, Nakamura et: al., eds.,
  • the invention provides several features that will be found advantageous in most, or all, types of assays.
  • the invention provides a method to analyze many different analytes in a sample all-at-once.
  • the method utilizes very small amounts of ABR to analyze a sample.
  • very small amounts of sample are used.
  • reagents are employed, the most highly preferred embodiments of the invention use very small amounts of these reagents as well. Similar considerations apply to the sample.
  • An alternative to liquid or gas reagents delivered by an autoanalyser may be preferred in low use and/or remote environments.
  • development reagents may be provided as part of the platform which will incorporate a device for controlling delivery of the reagents to the assays effective for properly developing results.
  • the reagents are in a gel in a geometry that provides reagent assay contact effective for proper development when the gel is extruded unidirectionally across the assays following appropriate exposure to sample. It will be appreciated by analogy that the operation of this embodiment of the invention is akin to the self- developing films that have been marketed by Kodak and Polaroid, among others, although the analogy should not be taken too literally.
  • each assay in an array may be designed to perform well under certain specified conditions to be employed.
  • the assays in a given array might all desirably be designed to work well with a given autoanalyzer of limited flexibility and narrow dynamic range of detection.
  • the amount of ABR can be adjusted for each assay to work well within the available dynamic range.
  • the amount of a detecting reagent or the amount of label in the detecting reagent may be adjusted.
  • the amount of first antibody immobilized on the surface may be varied for each assay to work well with the expected sample in the available protocols and detection regimes of the analyzer.
  • the amount of second antibody that binds to the antigen also can be controlled, by its concentration in the second antibody mix.
  • the degree of labeling of a detection reagent such as a fluorescent tag or biotin affinity label on a secondary antibody, can be adjusted to help insure that the signal from each assay is within the working range of the analyze.
  • each first antibody may be separately immobilized, each second antibody can be separately biotinylated, and many assays can be tested simultaneously in a given autoanalysisr protocol. It will almost always be possible to adjust the parameters of any particular assay to a standard protocol.
  • the invention is useful for, among many other things, carrying out any assay predicated on binding of one member of a binding to the other, such as binding of an analyte binding reagent and cognate analyte.
  • any assay predicated on binding of one member of a binding to the other such as binding of an analyte binding reagent and cognate analyte.
  • Numerous assays have been described and are well known to those of skill in the art that can be usefully employed in accordance with the present invention. Many such techniques are set out in some detail in, for instance, BIOSENSORS, AN
  • immunological reagents are used, particularly antibody-derived reagents.
  • oligonucleotide and/or PNA reagents are used.
  • Other preferred embodiments relate to organic affinity reagents (ABRs), such as polyamides that can bind DNAs sequence-specifically.
  • ABRs organic affinity reagents
  • Still other preferred embodiments relate to random "sequence" polymers, such as random sequence DNAs, screened for analyte-binding ability and then used as ABRs.
  • ABRs organic affinity reagents
  • Some preferred embodiments of the invention relate to high affinity and specificity ABRs, while other preferred embodiments relate to lower affinity and lower specificity ABRs.
  • low affinity and/or low specificity ABRs are embodiments of the invention in which analytes are determined by patterns of binding to sets of ABRs. Still further preferred embodiments relate in this regard to combinations of ABRs with differing specificity, affinity and avidity for their cognate analytes. Particularly preferred embodiments use information from a variety of such ABRs to determine an analyte.
  • sandwich assays are used in the invention.
  • first antibodies specific for cognate antigens are immobilized in an array, in accordance with methods described herein above.
  • the array is exposed to a sample under conditions effective for antibodies in the array to bind cognate antigens in the sample. Thereafter, the array is washed and then exposed to second antibodies that bind to the cognate antigens under conditions effective for the secondary antibodies to form Ab1 -cognateAg-Ab2 sandwiches with cognate antigens bound to first antibodies in the array.
  • the formation of the sandwiches then is detected, thus detecting the presence of the cognate antigens in the sample.
  • Detection can be qualitative or quantitative.
  • the second antibodies in sandwich assays are detected independently of the first antibodies.
  • the first antibodies might be mouse monoclonals and the second antibodies might be goat polyclonals.
  • first and second antibodies both may be mouse monoclonal, but all the second antibodies will have been covalently bonded to a detectable label, such as a fluorescent label.
  • Other labels of which many are know to those of skill in the art, can be used. Non-diffusing labels are preferable in some situations, where diffusion would preclude accurate localization, for instance.
  • solution ELISAs also can be used in some embodiments.
  • second antibodies may be attached to a chemical hook which subsequently attaches the detectable label.
  • the well known avidin-biotin system can be used in this way.
  • the secondary antibodies can be tagged with biotin, a fluorescent label can be attached to avidin, and the presence of cognate antigens can be detected by fluorescence of labeled avidin that binds to biotinylated secondary antibodies in Ab1-cognateAg-Ab2 sandwiches formed on the array.
  • hybridization assays and methods for detecting hybridization are also particularly useful in the invention.
  • Such assays can take a wide variety of formats and are well known to those of skill in the art.
  • Particularly preferred for use in accordance with the present invention are assays that work well in a solid- phase format in which a capture probe is immobilized on a solid phase, such as a surface, and localizes specific hybridization thereto.
  • polynucleotides in the sample are labeled and their hybridization to the probe polynucleotides (or PNAs) on the chip are detected directly.
  • the labels generally are fluorescent in common implementations of this approach; but, many other types of label can be used, as discussed elsewhere herein.
  • Another approach to such methods is based on primer elongation, exemplified by the following method for simultaneous analysis of a plurality of polynucleotides in a sample, which comprises the steps of: (A) providing a surface having immobilized in a predetermined pattern thereon a plurality of first oligonucleotide probes stably hybridizable specifically to one or more polynucleotides, wherein the first oligonucleotide probes provide 3' hydroxyl groups for elongation, and wherein each position in the predetermined pattern exclusively contains a first oligonucleotide probe or mixture of probes specific for a polynucleotide or mixture of polynucleotides of the plurality of polynucleotides;
  • the detectable label is a fluorescent label. In other preferred embodiments other types of labels are employed. Also preferred are mass tags for mass spectral detection and analysis. Also preferred in certain embodiments of this aspect of the invention are methods wherein the polymerase is a DNA polymerase and one, two, three or all four of the deoxyribonucleotide triphosphates are detectably labeled with a fluorescent label. In other preferred embodiments in this regard the polymerase is a reverse transcriptase and one, two, three or all four of the deoxyribonucleotide triphosphates are detectably labeled. In certain preferred embodiments in both regards, fluorescent labels are preferred.
  • certain preferred embodiments are those in which the T m or T d of duplexes formed by hybridization of sample polynucleotides to immobilized probes are within 1 , 2, 3, 4, 5 or 10 degrees centigrade of one another. Particularly preferred are those in which the duplexes are within 1 , 2 or 3 degrees centigrade under the conditions used for hybridization.
  • Also useful in the invention are methods for simultaneous analysis of a plurality of polynucleotides in a sample, comprising the steps of: (A) providing a surface having immobilized in a predetermined pattern thereon a plurality of first oligonucleotide probes stably hybridizable specifically to the polynucleotides, wherein the first oligonucleotide probes provide 3' hydroxyl groups, and wherein each position in the predetermined pattern exclusively contains a first oligonucleotide probe or mixture of probes specific for a polynucleotide of the plurality of polynucleotides; (B) contacting the surface with a sample under conditions effective to hybridize polynucleotides in the sample specifically to the first oligonucleotide probes immobilized on the surface; (C) separating from the surface components of the sample other than polynucleotides specifically hybridized to the immobilized first oligonucleotide probes on the surface;
  • step (G) additionally comprises melting the polynucleotides hybridized to the first and second oligonucleotide probes, whereby detectably labeled second oligonucleotide probes ligated to first oligonucleotide probes remain bound to the surface via the first oligonucleotide probes immobilized on the surface in the predetermined pattern, and the other polynucleotides are removed.
  • the immobilized probe contains two labels that interact through an energy transfer mechanism that is affected by duplex formation.
  • the energy transfer is detectably altered by probe-target binding in a way that enables analyte detection and determination.
  • the two label can exchange energy by Forster energy transfer.
  • Forster energy transfer efficiency is proportional to the inverse sixth power of the distance between the two labels. Accordingly, it is very sensitive to their proximity. If duplex formation moves the labels even slightly apart energy transfer between them will decline dramatically.
  • the effect is well known to those of skill in the art, and it has been used to measure the relative motion of different parts of various molecules, such as polynucleotides and proteins. Its application in accordance with the present invention can proceed using much the same kinds of techniques, adapted to the solid phase array.
  • detection techniques may be employed in the invention for reading-out analyte determinations on a chip.
  • the detection techniques may rely on any of a wide variety of detectable labels.
  • Such detection techniques and detectable labels are well know and are described in numerous primary publications, technical manuals, laboratory handbooks and textbooks, to name a few. These detection technologies are described in such publications both generally and with respect to specific types of assays and assay procedures.
  • such techniques can be employed in the present invention, particularly those that have already been adapted to detection of binding to genechips and other types of solid-state arrays.
  • BIOSENSORS AN INTRODUCTION, Wiley and Teubner, Chichester and Stuttgart (1996), HANDBOOK OF BIOSENSORS AND ELECTRONIC NOSES, MEDICINE, FOOD, AND THE ENVIRONMENT, Erika Kress-Rogers, ed., CRC Press, Boca Raton (1997) and IMMUNOCHEMICAL
  • detection can determine both the presence of a detectable label and its position, relative to other positions in an array on a chip. Both abilities can be attained by a variety of means. For instance, detection may involve acquiring an image of a chip that comprises an image of the detectable label in each element and/or assay area, and then, by image processing, determining the results for each assay. Such image processing may be quantitative, threshold-related or qualitative.
  • the chip may be scanned, raster fashion, or quasi-raster fashion, or along a path (ray-tracing mode) so detection is carried out discretely for each element and/or assay area.
  • Each element and/or assay area thus may be detected one or more times in the same or in different portions, and the detection may involve averaging or otherwise processing such repeated samplings.
  • the sampling furthermore may involve detection of each element and/or assay area along a beam line, such as for an absorption assay, or it may involve stimulation by a beam line and detection of an emitted signal, such as fluorescence. In the latter case, the emitted signal may be measured over a spot or a wide area.
  • the entire chip (or portions thereof) can be excited en Scotland and the signal coming from elements and/or assay areas then measured individually.
  • several beams and detectors can be arranged to work in parallel in any such detection paradigm. Spatial resolution may be obtained by tracking the motion and the position of a scanning beam (or other scanning means) as it moves with respect to a chip, by tracking the position of the chip as it moves with respect to the beam, or by a combination of the two.
  • alignment markers integrated into the chip, sub-assembly, matrix and/or matrix carrier can provide internal alignment and registration signals that can be used by the detector and its associated hardware and software to correlate elements and assays on a chip with the detected signals.
  • alignment and registration signals can be incorporated into chips as pseudo- analytes at the time the chip is made.
  • the markers can be "etched" or written onto the chip outside the elements and the element- containing portion of the assay areas at the time the chips are made.
  • Suitability of detection techniques for use in the invention can be assessed by reference to the following parameters.
  • the detection accuracy should be high. Preferably, the accuracy is within
  • analyte binding to every assay area on a chip can be detected and/or determined for each sample.
  • the detector must be able to resolve the elements and assay areas, and it must be able to detect the signal in such areas that samples for analysis will provide.
  • detectors for use in the invention presently are available. Suitable detectors range from inexpensive scanners for use with PC's to sophisticated photon counting imaging microscopes. As noted above, different detectors will be preferred in different embodiments of the invention. Thus, for economical mass production greater economy will be desirable. For other applications very high resolution, sensitivity and dynamic range may be more important. The few examples below, therefore, are merely illustrative. Sophisticated and sensitive apparatus for detection is available that can be used for clinical and other applications in which large numbers of samples are analyzed, or where equipment expense is not as important as sensitivity, speed and accuracy.
  • fluorescence detectors of the type used on automated DNA sequences can be adapted for use in the present invention, for detection of one, two, three, four or even more fluorescent dyes.
  • fluorescence detectors described by Affymax and Affymetrics for detecting binding to peptide and oligonucleotide arrays are readily adaptable for use in accordance with the present invention.
  • many laser scanning detectors now used for biochip detection, including laser-ablation mass spectroscopy scanning detectors are readily employed as detectors in accordance with the present invention.
  • the devices have in common that they scan an image surface with a laser beam and measure the light reflected from the surface along the scan path.
  • the scan line typically is very thin, 1/100 to 1/400 inches in inexpensive scanners.
  • the full image is digitized by serially scanning the image surface in the direction perpendicular to the scan line.
  • scanners typically move paper in steps after each line scan to build up the two dimensional image of the paper surface.
  • With hand-held scanners the perpendicular movement is performed manually. It will be appreciated that the scanning mechanism is compact and economical in these devices.
  • a relatively inexpensive hand-held color scanner can resolve 400 dpi in both dimensions, i.e., 16,000 pixels per square inch. Resolution is in three colors with a grey scale range of 256 levels.
  • the detection system can read coded information on the chip in addition to assay test results.
  • Many types of information can be coded, in many formats.
  • One type of information is positional, such as the alignment and registration information discussed elsewhere herein. Such information primarily is useful to allow identification of elements and assay areas with the detected binding, so that signals can be matched to corresponding elements and/or assays. Such information generally can be imprinted at the time the chip is manufactured.
  • Another type of information provides information about the chip itself — its manufacturing lot, for instance. This information, at least in part, can be used to match software to chips so that the results of assays can be calculated and accurately reported. Thus, for instance, the information about each element and assay area in each lot of chips on a given carrier can be recorded in software.
  • the software thus can contain the identity, location, standardization curves and other information about each chip in the carrier necessary for read-out of assay results.
  • the software thus allows great flexibility to chip manufacture, since the location of elements and assays, as well as standardization can be changed from lot to lot in a way that is transparent to the end-user.
  • the ability to identify carriers and chips and match the software to the detected lots provides a way to do this.
  • Such information can include expiration dates for elements, assays and/or carriers that would key an instrument to exclude their use.
  • a third type of "embedded" information can be provided by the user at the time of use, such as a clinician at the time sample is applied. It is highly preferable for the instrument of analysis to be able to capture these types of information, as well as detect the signals arising from analyte binding.
  • Such information can be embedded in chips, sub-assemblies, matrixes, matrix carriers, and the like in many ways. It can be incorporated during manufacturing of chips by the use of pseudo-analytes. These are signal- generating molecules, compounds, compositions, materials, substances or the like, that generate a position-specific signal for detection. The signal may be intrinsic thereto or it may arise from the analytical process, along with the signals from genuine analytes. Such embedding may be in elements of an assay area or it may be outside assay areas or both. In fact, it can in principle be anywhere on the chip. Specific areas on a chip may be dedicated to these markers, so that the signals always arise from the same areas on chips and/or the markers can be incorporated into different places on different chips or chip runs.
  • markers can be dedicated to the markers or they can be areas that could also contain ABRs.
  • the signal from the markers can be detected in the same way as analyte binding is detected or it can be detected differently. For instance, one or more colors in a multicolor detection scheme can be used exclusively for marker detection. When such a multiplexing approach is used, the markers may even be incorporated with ABRs in elements of a chip. Particularly accurate alignment can be facilitated by multiplexing.
  • Such information can be directly imprinted on chips or within a manufacturing ribbon or other substrate, for instance. Particularly, certain kinds of lot and registration information may be so imprinted. The information may also be incorporated at the time of dicing or wafering.
  • Information of this type may take many forms, but preferably is machine detectable and readable by computer systems.
  • the information can be in the form of shapes, bar codes and/or print, that can be acquired and interpreted by the detector and computer analysis methods and systems useful in the invention.
  • the detector and computer analysis methods and systems useful in the invention can be employed in this regard in the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Composite Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés permettant de créer des réseaux, des dispositifs destinés à cet effet, lesdits réseaux, les utilisations desdits réseaux ainsi que des dispositifs permettant d'utiliser lesdits réseaux. Dans un aspect, l'invention concerne des procédés permettant de créer un grand nombre de réseaux. Selon un autre aspect, l'invention concerne la fabrication de réseaux par répétition d'un cycle d'exposition d'un substrat à des éléments du réseau, par activation des régions du substrat et par liaison desdits éléments du réseau aux régions activées, enfin par retrait de la matière non liée du substrat. De préférence, le substrat est constitué de canaux contenant de longs rubans, des groupes successifs d'éléments du réseau sont introduits dans lesdits canaux et les éléments de réseau introduits sont liés de manière photochimique à des régions choisies définies par photolithographie. Un mode de réalisation particulier concerne des réseaux de détermination de l'analyte, tels que des réseaux d'ADN, et leurs utilisations.
PCT/US1999/023860 1998-10-16 1999-10-15 Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes WO2000023803A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002347125A CA2347125A1 (fr) 1998-10-16 1999-10-15 Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes
AU65158/99A AU6515899A (en) 1998-10-16 1999-10-15 Methods of making patterned arrays of analyte-binding molecules

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10464298P 1998-10-16 1998-10-16
US10464398P 1998-10-16 1998-10-16
PCT/US1998/021860 WO1999019711A1 (fr) 1997-10-16 1998-10-16 Procede de production de matrices et dispositifs y relatifs
US60/104,643 1998-10-16
USPCT/US98/21860 1998-10-16
US60/104,642 1998-10-16

Publications (1)

Publication Number Publication Date
WO2000023803A1 true WO2000023803A1 (fr) 2000-04-27

Family

ID=27378546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/023860 WO2000023803A1 (fr) 1998-10-16 1999-10-15 Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes

Country Status (3)

Country Link
AU (1) AU6515899A (fr)
CA (1) CA2347125A1 (fr)
WO (1) WO2000023803A1 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051058A1 (fr) * 1999-02-26 2000-08-31 General Scanning, Inc. Imagerie automatique et analyse de biopuces d'ensembles de microechantillons
WO2002018945A2 (fr) * 2000-08-30 2002-03-07 Basf-Lynx Bioscience Ag Puce d'analyse
EP1226866A2 (fr) * 2001-01-29 2002-07-31 Agilent Technologies, Inc. (a Delaware corporation) Production de matrices chimiques avec carte d'identification
EP1247570A2 (fr) * 2001-03-30 2002-10-09 Agilent Technologies, Inc. Lecture d'un array chimique
EP1358939A2 (fr) * 2002-04-29 2003-11-05 Agilent Technologies, Inc. Support pour matrices de micro-échantillons
EP1415788A1 (fr) * 2002-10-31 2004-05-06 Agilent Technologies, Inc. Dispositif de reseau microfluidique integre
WO2005019818A2 (fr) * 2003-08-19 2005-03-03 Micronas Gmbh Element support pour l'analyse d'une substance
WO2005024695A2 (fr) * 2003-09-03 2005-03-17 Agilent Technologies, Inc. Procedes pour coder des informations non biologiques sur des microreseaux
WO2006050617A1 (fr) * 2004-11-12 2006-05-18 Eidgenössische Technische Hochschule Zürich Dispositif microfluidique destine a la modification d'une surface a motif
US7364896B2 (en) 2002-10-31 2008-04-29 Agilent Technologies, Inc. Test strips including flexible array substrates and method of hybridization
US7718421B2 (en) 2003-02-05 2010-05-18 Iquum, Inc. Sample processing
US7785535B2 (en) 2004-06-07 2010-08-31 Iquum, Inc. Sample multiprocessing
US7833489B2 (en) 1998-06-24 2010-11-16 Chen & Chen, Llc Fluid sample testing system
US7935504B2 (en) 2000-12-29 2011-05-03 Chen & Chen, Llc Thermal cycling methods
US9005551B2 (en) 1998-06-24 2015-04-14 Roche Molecular Systems, Inc. Sample vessels
CN109900814A (zh) * 2017-12-08 2019-06-18 中国科学院大连化学物理研究所 一种基于糖苷键质谱可碎裂型化学交联剂的分析方法及应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948442A (en) * 1985-06-18 1990-08-14 Polyfiltronics, Inc. Method of making a multiwell test plate
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
WO1996003212A1 (fr) * 1994-07-26 1996-02-08 Sydney Brenner Dispositif multidimensionnel a canaux destine a la synthese d'une banque combinatoire
US5677195A (en) * 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
WO1999032219A1 (fr) * 1997-12-19 1999-07-01 Glaxo Group Limited Systemes et procedes de synthese parallele en phase solide
US5929208A (en) * 1993-11-01 1999-07-27 Nanogen, Inc. Methods for electronic synthesis of polymers

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948442A (en) * 1985-06-18 1990-08-14 Polyfiltronics, Inc. Method of making a multiwell test plate
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5677195A (en) * 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5929208A (en) * 1993-11-01 1999-07-27 Nanogen, Inc. Methods for electronic synthesis of polymers
WO1996003212A1 (fr) * 1994-07-26 1996-02-08 Sydney Brenner Dispositif multidimensionnel a canaux destine a la synthese d'une banque combinatoire
WO1999032219A1 (fr) * 1997-12-19 1999-07-01 Glaxo Group Limited Systemes et procedes de synthese parallele en phase solide

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022722B2 (en) 1998-06-24 2018-07-17 Roche Molecular Systems, Inc. Sample vessels
US7833489B2 (en) 1998-06-24 2010-11-16 Chen & Chen, Llc Fluid sample testing system
US9005551B2 (en) 1998-06-24 2015-04-14 Roche Molecular Systems, Inc. Sample vessels
WO2000051058A1 (fr) * 1999-02-26 2000-08-31 General Scanning, Inc. Imagerie automatique et analyse de biopuces d'ensembles de microechantillons
WO2002018945A2 (fr) * 2000-08-30 2002-03-07 Basf-Lynx Bioscience Ag Puce d'analyse
WO2002018945A3 (fr) * 2000-08-30 2002-06-27 Basf Lynx Bioscience Ag Puce d'analyse
US8148116B2 (en) 2000-12-29 2012-04-03 Chen & Chen, Llc Sample processing device for pretreatment and thermal cycling
US9662652B2 (en) 2000-12-29 2017-05-30 Chen & Chen, Llc Sample processing device for pretreatment and thermal cycling
US7935504B2 (en) 2000-12-29 2011-05-03 Chen & Chen, Llc Thermal cycling methods
EP1226866A3 (fr) * 2001-01-29 2003-12-10 Agilent Technologies, Inc. (a Delaware corporation) Production de matrices chimiques avec carte d'identification
EP1226866A2 (fr) * 2001-01-29 2002-07-31 Agilent Technologies, Inc. (a Delaware corporation) Production de matrices chimiques avec carte d'identification
EP1247570A3 (fr) * 2001-03-30 2003-12-17 Agilent Technologies, Inc. Lecture d'un array chimique
EP1247570A2 (fr) * 2001-03-30 2002-10-09 Agilent Technologies, Inc. Lecture d'un array chimique
EP1358939A2 (fr) * 2002-04-29 2003-11-05 Agilent Technologies, Inc. Support pour matrices de micro-échantillons
EP1358939A3 (fr) * 2002-04-29 2005-04-27 Agilent Technologies, Inc. Support pour matrices de micro-échantillons
US7125523B2 (en) 2002-04-29 2006-10-24 Agilent Technologies, Inc. Holders for arrays
US7364896B2 (en) 2002-10-31 2008-04-29 Agilent Technologies, Inc. Test strips including flexible array substrates and method of hybridization
EP1415788A1 (fr) * 2002-10-31 2004-05-06 Agilent Technologies, Inc. Dispositif de reseau microfluidique integre
US7390457B2 (en) 2002-10-31 2008-06-24 Agilent Technologies, Inc. Integrated microfluidic array device
US9708599B2 (en) 2003-02-05 2017-07-18 Roche Molecular Systems, Inc. Sample processing methods
US7718421B2 (en) 2003-02-05 2010-05-18 Iquum, Inc. Sample processing
US10443050B2 (en) 2003-02-05 2019-10-15 Roche Molecular Systems, Inc. Sample processing methods
US8936933B2 (en) 2003-02-05 2015-01-20 IQumm, Inc. Sample processing methods
WO2005019818A3 (fr) * 2003-08-19 2005-06-02 Micronas Gmbh Element support pour l'analyse d'une substance
WO2005019818A2 (fr) * 2003-08-19 2005-03-03 Micronas Gmbh Element support pour l'analyse d'une substance
WO2005024695A3 (fr) * 2003-09-03 2005-11-03 Agilent Technologies Inc Procedes pour coder des informations non biologiques sur des microreseaux
WO2005024695A2 (fr) * 2003-09-03 2005-03-17 Agilent Technologies, Inc. Procedes pour coder des informations non biologiques sur des microreseaux
US8414845B2 (en) 2004-06-07 2013-04-09 Iquum, Inc. Sample multiprocessing
US7785535B2 (en) 2004-06-07 2010-08-31 Iquum, Inc. Sample multiprocessing
WO2006050617A1 (fr) * 2004-11-12 2006-05-18 Eidgenössische Technische Hochschule Zürich Dispositif microfluidique destine a la modification d'une surface a motif
CN109900814A (zh) * 2017-12-08 2019-06-18 中国科学院大连化学物理研究所 一种基于糖苷键质谱可碎裂型化学交联剂的分析方法及应用
CN109900814B (zh) * 2017-12-08 2021-06-08 中国科学院大连化学物理研究所 基于糖苷键质谱可碎裂型化学交联剂的分析方法及应用

Also Published As

Publication number Publication date
AU6515899A (en) 2000-05-08
CA2347125A1 (fr) 2000-04-27

Similar Documents

Publication Publication Date Title
US10927406B2 (en) Microarray system and a process for detecting target analytes using the system
US6309831B1 (en) Method of manufacturing biological chips
WO2000023803A1 (fr) Procedes permettant de creer des reseaux a motifs de molecules de liaison d'analytes
US6908737B2 (en) Systems and methods of conducting multiplexed experiments
US6929944B2 (en) Analysis using a distributed sample
US20030134330A1 (en) Chemical-library composition and method
US20030157700A1 (en) Apparatus and methods for constructing array plates
US20050221351A1 (en) Methods and devices for microarray image analysis
US20070134699A1 (en) Nano-scale ligand arrays on substrates for particle beam instruments and related methods
US20030036096A1 (en) Chemical-library composition and method
WO1999060170A1 (fr) Reseaux lineaires de composes immobilises et procedes d'utilisation de ces derniers
US20040038388A1 (en) Manufacturing process for array plate assembly
US8093186B2 (en) Biopolymeric arrays having replicate elements
US7642097B2 (en) Manufacture and use of non-standard size microarray slides
WO1999019711A1 (fr) Procede de production de matrices et dispositifs y relatifs
US20020155495A1 (en) Method for producing arrays and devices relating thereto
US20040115722A1 (en) Biopolymeric arrays and methods of producing the same
US20070020668A1 (en) Method of manufacturing
US20060057023A1 (en) Chemical arrays assemblies and devices and methods for fabricating the same
US20020168655A1 (en) Method of manufacturing
US20050277122A1 (en) Devices and methods for contacting fluid with a chemical array

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 1999 65158

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: US

Ref document number: 2000 529588

Date of ref document: 20000417

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2347125

Country of ref document: CA

Ref country code: CA

Ref document number: 2347125

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09807502

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase